MedTrace Logo

Feasibility Study of Receiving Feedback Messages Based on Self-monitored Dietary Intake

NCT02829632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2016-12-05

No results posted yet for this study

Summary

Brief Summary: This randomized clinical pilot will test the feasibility of having individuals self-monitor for 12 weeks and based on what the participants record be given feedback messages. The investigator will use this information to refine the questions and data collection procedures for the larger study.

Participants will be randomized into 3 groups

* self-monitoring only
* self-monitoring w/ feedback messages
* self-monitoring w/feedback messages and group sessions Feedback messages will be delivered up to 4 times per day using a different schedule. The group sessions will be held in the 2nd, 4th and 8th week of the 12-week study.

All participants will be asked to complete questionnaires and 2 assessment visits at baseline and 12 weeks.

Conditions

Interventions

BEHAVIORAL

Group Sessions

Participants will receive a 3-session behavioral lifestyle program for a healthful lifestyle and weight loss.

BEHAVIORAL

Feedback

Participants will receive up to 4 daily feedback messages based on progress in attaining target behavior. The feedback messages will be delivered on a variable ratio schedule and tailored to data in subjects' dietary recordings.

BEHAVIORAL

Self-monitoring

Participants will receive an one-time how to self-monitor using the smartphone session.

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02829632 on ClinicalTrials.gov